If you’ve been meaning to talk to your vet about updating your dog’s vaccines before summer gets fully underway, the timing just got more interesting. On June 15, 2026, the USDA approved Elanco’s TruCan Ultra Lyme-L4, the first combination vaccine to protect dogs against both Lyme disease and leptospirosis in a single 0.5 mL injection. For anyone who’s watched their dog flinch through multiple shots at annual wellness visits, or who has tried to keep track of which boosters are actually current, this is genuinely useful news.

What This Vaccine Actually Is (and Why the Size Matters)

Vaccine CharacteristicTruCan Ultra Lyme-L4Traditional Separate Vaccines
Injection volume0.5 mL1 mL (combination options)
Lyme efficacy (endemic areas)92.2%Varies by product
Lyme efficacy (lab conditions)100%Varies by product
Lepto serovar coverageL4 (four-serovar)L2 or L4 depending on product
Number of injections requiredOneTwo (separate appointments)
Expected availabilityMid-July 2026Immediate
Formulation technologyPureFil TechnologyVaries by product

You might be wondering: isn’t there already a Lyme vaccine? Yes, there are several. And lepto vaccines have been around for years. What’s new here is the combination, and the delivery.

TruCan Ultra Lyme-L4 is a 0.5 mL injection, half the volume of the existing 1 mL combination options. That might sound like a minor detail, but it’s not. Smaller injection volumes are associated with reduced site reactions, and Elanco built this product around their proprietary PureFil Technology, which is specifically designed to remove unwanted proteins that tend to drive post-vaccination soreness and immune responses. For a dog who’s already a little needle-shy, or a giant breed who seems to have no reaction to anything, or especially a small dog who’s historically had some puffiness or lethargy after vaccines, this matters. Less volume, cleaner formulation.

The efficacy numbers are strong. According to the Elanco press release, the vaccine showed 92.2% efficacy against natural infection in highly endemic areas, and 100% efficacy in controlled laboratory challenge studies. Those aren’t the same thing, and it’s worth understanding the difference. Lab conditions are controlled by design. Real-world endemic conditions are messy, which makes that 92.2% figure the more meaningful one for most dogs living in tick country.

The Gap This Is Filling Is Bigger Than You’d Think

Helpful resource: FRONTLINE Plus Flea and Tick Treatment for Dogs is a top-rated option for this. (As an Amazon Associate this site earns from qualifying purchases.)

Here’s something that genuinely surprised me when I first saw the data: according to Elanco, over 40% of at-risk dogs in Lyme-endemic states don’t have a current Lyme vaccine, even though they’ve received their core vaccines on schedule. That’s a significant gap, and it’s not because owners don’t care.

What tends to happen is that Lyme and lepto have historically required separate appointments, separate charges, and sometimes separate conversations with a vet who may or may not bring it up proactively. Lyme is often framed as a “lifestyle” vaccine, meaning it gets recommended based on individual risk assessment rather than universally. If your vet doesn’t know you hike on wooded trails every weekend, or if your dog mostly stays in the backyard in a suburban area that borders conservation land, you might have slipped through without it.

The lepto piece has actually shifted significantly in recent years. The American Animal Hospital Association now classifies leptospirosis as a core vaccine for all dogs, regardless of breed, lifestyle, or geographic location. Not high-risk dogs. All dogs. The reasoning is that lepto is transmitted through water and soil contaminated by infected wildlife urine, and wildlife is everywhere, including suburban yards, dog parks, and puddled driveways after a rainstorm. If your vet hasn’t had this conversation with you recently, it’s worth raising.

What You Should Actually Do with This Information Right Now

Elanco expects the vaccine to begin shipping within 30 days of the June 15 approval, which means it should be moving through distribution channels and arriving at veterinary clinics by mid-July 2026. It won’t be on every shelf by next week, but it’s not a distant future product either.

Here’s what I tell people: don’t wait to find out if your specific clinic has TruCan Ultra Lyme-L4 yet before having the underlying conversation with your vet. The vaccine approval is a good reason to call and ask three things: Is my dog current on Lyme? Is my dog current on lepto, including the L4 serogroup coverage? And should we wait for this new combination product or move forward with what’s available now?

That last question has a real answer that depends on your dog’s situation. If your dog is already past due on either vaccine and you’re in a high-tick area, waiting a few extra weeks for a newer product isn’t necessarily the right call. If your dog is current on lepto but has never had Lyme protection, that gap is worth closing soon regardless of which product gets used. Your vet can walk you through the timing, and as dvm360 reported in their June 15 coverage of the approval, the combination format is designed specifically to improve compliance and close exactly this kind of coverage gap.

The Lepto Serogroup Question Most People Don’t Know to Ask

One thing that doesn’t come up enough in casual conversations about lepto vaccines is that not all of them cover the same strains. Leptospirosis is caused by different serovars, and coverage varies by product. The “L4” in TruCan Ultra Lyme-L4 refers to four-serovar lepto coverage, which is the broader protection. Some older lepto vaccines only covered two serovars.

If your dog has been getting lepto vaccinated for years, you might be wondering whether they’ve actually been getting the four-serovar version. It’s a fair question. Pull up their vaccination records, look at the product name, and if you’re not sure, ask your vet’s office to check. This isn’t meant to alarm you, it’s just useful information to have when you’re trying to understand whether your dog’s current protocol is truly comprehensive or has a gap you didn’t know about.

The combination vaccine format, and the fact that it’s designed from the ground up around both diseases in a single low-volume injection, represents a meaningful step forward in how we approach preventive care for dogs in endemic regions. As Outbreak News Today noted in their June 18 coverage, this is a first-of-its-kind product in terms of its delivery profile and combined scope.

We’re in peak tick season right now, and lepto risk stays elevated through late fall in most of the country. If your dog’s protection isn’t fully current, this is a good week to make that call.

Sources


This article is for general informational purposes only and does not constitute veterinary advice. Pet health symptoms can have many causes and require professional evaluation. Always consult a licensed veterinarian for diagnosis and treatment specific to your pet.



Disclosure: As an Amazon Associate, we earn a small commission from qualifying purchases at no extra cost to you. We only recommend products that genuinely support the topics covered in this article.